A comment on the damages provision in the USMCA IP Chapter was published on April 2, 2019, in Harvard’s Bill of Health blog, here.
Open letter on NIST Draft Green Paper on Bayh-Dole Act Policies and Regulations 5 April 2019 FMI: Claire Cassedy, claire.cassedy@keionlineorg +1.202.332.2670 Washington, 5 April 2019 – Eleven non-governmental organizations have sent a letter to members of the US Congress, highlighting… Continue Reading
KEI intervention at SCCR 38, on copyright limitations and exceptions April 3, 2019 KEI suggests the WIPO SCCR increase its ambitions on access to knowledge, making it more political, and while more challenging, more worth the investment of time and… Continue Reading
>> CHAIR: Thank you. I now give the floor to the delegate from the United States of America. America (Speaker) thank you, Mr. Chair. The United States would first like to congratulate you on your election and to thank you… Continue Reading
On Monday, 1 April 2019, Knowledge Ecology International (KEI) delivered the following oral statement to the Open Session of the 22nd Meeting of the WHO Expert Committee on the Selection and Use of Essential Medicines. The program for the open… Continue Reading
Day 1 of SCCR 38. There is definitely more support for the broadcasting treaty, “a momentum” said a delegate, and it is difficult to find a delegation that would oppose, at least publicly, this 20 year old effort. NGO observers… Continue Reading
On July 19, 2018, the U.S. District Court, Northern District of California, denied a permanent injunction requested by Illumina, Inc, and instead ruled that a forward looking royalty for continued non-voluntary use of the invention, a type of compulsory license,… Continue Reading
The following was sent to US DOJ today, to express KEI’s opposition to the IBM acquisition of Red Hat. 13 March 2019 Bindi R. Bhagat U.S. Department of Justice Antitrust Division Technology and Financial Services Section Dear Ms. Bhagat, Thank… Continue Reading
On March 6, 2019, 83 civil society organizations and 20 individuals asked delegates to the World Health Assembly (WHA) to support a proposed resolution on “Improving the transparency of markets for drugs, vaccines and other health-related technologies.” A copy of… Continue Reading
PhRMA’s Special 301 submissions are part of a yearly ritual to shape the “Special 301” Report, an annual review of the global state of intellectual property rights (IPR) protection and enforcement, conducted by the Office of the United States Trade… Continue Reading